Dr. Charles Cantor joined Moscow Institute of Physics and Technology as Adjunct Professor

DOLGROPRUDNY, Russian Federation - March 28, 2013 - PRLog -- Dr. Charles Cantor joined Moscow Institute of Physics and Technology as Adjunct Professor

   03.28.2013, Moscow, Russia - The Moscow Institute of Physics and
Technology (Russian State University) announced today that a world leading
scientist in the genetics field Dr. Charles Cantor has become Adjunct

Dr. Cantor is a member of the US National Academy of Sciences. He is also professor emeritus of Biomedical Engineering and Pharmacology at Boston University and adjunct professor of bioengineering at U.C. San Diego, distinguished adjunct professor of Physiology and Biophysics at U.C. Irvine, and adjunct professor of Molecular Biology at The Scripps Research Institute. He remains active in research at Boston University through a number of collaborations between his companies Sequenom and Retrotope and a number of academic groups. Published more than 450 articles, more than 65 patents and co-authored a three-volume textbook on Biophysical Chemistry.

Dr. Cantor's current research interests include developing non-invasive diagnostics tests for cancer, inflammation, neurodegenerative disease and other clinical presentations using cell free DNA sequences, epigenetically modified DNAs, RNAs and proteins; elucidating the mechanism by which certain site specifically fatty acids protect against oxidative stress, and using nucleic acid or nucleic acid-protein nanostructures as detectors in both biology and physics.

"I am honored and pleased to be able to interact now directly with the superb students and faculty at the MIPT. The border between biology and physics is currently a hot bed of innovation and I hope to be able to guide activities at MIPT towards some of the important aspects of this interface. One of my current interests is trying to use the currently available biological tools to synthesize and replicate nanoscale objects to serve as elements of nanoscale physics detectors and other functional elements. Another current interest is pushing the boundaries of quantitative molecular detection sensitivity to overcome limits caused by stochastic sampling noise. Both of these activities should be assisted significantly by the kinds of interactions between physics and  biology that are possible at MIPT", said Dr. Charles Cantor.

"We are honored to have an opportunity to collaborate with Dr. Cantor. We firmly believe that this endeavor will become a milestone in the globalization of our university. The transfer of knowledge from world's top academic luminaries like Dr. Cantor will help advance medical science, and create a world-class advanced research center at MIPT", said rector of MIPT Nikolay Kudryavtsev.

“Having on board such an outstanding scientist should help a lot for development of biomedical science at MIPT. It will play an important role for international recognition of MIPT not only as a birthplace of outstanding graduates as it is well known for but also as a research Institution”, Alexander Melerzanov, Dean of the  Department  of  Biological and Medical Physics, commented.

"One of the first foreign biophysicists to visit the USSR, Dr. Charles Cantor is a living legend in the Russian genetics and molecular biology community. The translations of his influential "Biophysical Chemistry" book series occupy the prized places on the book shelves of top academics. The inventor of the Pulsed Field Gel Electrophoresis (PFGE) and ImmunoPCR, Dr. Cantor relentlessly generates cutting-edgeresearch in many areas of science including non-invasive prenatal diagnostics, oncology biomarkers and isotopically-fortified organic compounds. Dr. Cantor's expertise in turning basic research into commercially viable projects in order to fund and advance science is extremely valuable for the development of the “Northern” BioPharmCluster based on MIPT. We are honored to have Dr. Cantor join MIPT international faculty as the Adjunct Professor", said Oleg Korzinov, Executive Director of “Northern” BioPharmCluster.

About MIPT

The Moscow Institute of Physics and Technology is the leading institute of higher education of the Russian Federation, training highly-qualified specialist in various areas of modern science and technology. Moscow Institute of Physics and Technology (MIPT) was created in 1946 by Leading Soviet scientists and Government as an advanced educational and research Institution with primary concentration in Physics. MIPT quickly assumed a leading position in this field and became known internationally. It is difficult to overestimate the significance of MIPT for Soviet Physics and Science in general. Institute's graduates became academicians, leading specialists in nuclear research and rocket science, oceanology, biophysics, radiophysics and other numerous branches of Science. www.mipt.ru

About “Northern” BioPharmCluster

“Northern” BiopParmCluster is an association of the Moscow Institute of Physics and Technology with biotech and pharma companies operating with the support of the Ministry of Industry and Trade of the Russian Federation and Moscow Region Government. “Northern” aims at the creation of a belt of small innovation enterprises and corporate laboratories working in life sciences around the Moscow Institute of Physics and Technology. Besides ChemRar High Tech Center and the Moscow Institute of Physics and Technology, “Northern” includes such companies as Akrikhin, Protek Group, Geropharm, Pharmzaschita, Altonika, Quantum Pharmaceuticals and others. www.pharmcluster.ru
Email:***@chemrar.ru Email Verified
Tags:Health, Biotech
Location:Dolgroprudny - Moscow - Russian Federation
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Biopharmcluster Northern PRs
Trending News
Most Viewed
Top Daily News

Most Viewed
Top Daily News
PTC News

Mar 28, 2013 News

Like PRLog?
Click to Share